Enhancing antifungal stewardship: The educational and healthcare benefits of involving pharmacy students in audits
Antifungal stewardship is important for promoting quality care and tackling the emergence of drug resistance. Evaluation of the quantity and appropriateness of common antifungal prescriptions like fluconazole is essential in the development of these programmes. To perform a clinical audit of fluconazole prescribing and explore whether involvement of pharmacy students in this process was feasible and meaningful from both pharmacy student and health system perspectives. An audit was conducted of all fluconazole prescriptions from January 2024 to March 2024 at two Sydney hospitals. Trained pharmacy students, under the supervision of antimicrobial stewardship pharmacists and physicians, completed the audit using the Antifungal National Antimicrobial Prescribing Survey audit tool. Prescriptions were assessed for their compliance to guidelines and appropriateness. Data on pharmacy students' educational experience was collected by a 5-point Likert scale survey. A total of 145 fluconazole prescriptions were audited: 34 for empiric therapy, 56 for directed therapy, and 56 for prophylaxis. A total of 91 (62.8%) prescriptions were assessed as appropriate, 46 (31.7%) were inappropriate, and 8 (5.5%) were not assessable. Potential drug-drug interactions were identified in 17 patients receiving fluconazole doses of 200 mg or greater, of which three were clinically significant, requiring intervention. Students had positive experiences contributing to quality use of medicines, in terms of enjoyment, support, and education. Inappropriate fluconazole use was common. Pharmacy students made a positive contribution to the antifungal audit, promoting good stewardship practises for the hospital while accessing enhanced learning and development opportunities.
Authors
- Jan‐Willem C. Alffenaar (ORCID: https://orcid.org/0000-0001-6703-0288)
- Savannah Reali (ORCID: https://orcid.org/0009-0002-5651-2526)
- Daniel Nguyen
- Mark W. Douglas (ORCID: https://orcid.org/0000-0003-4621-3485)
- Matthew Watts (ORCID: https://orcid.org/0009-0009-5219-2976)
- Justin Beardsley (ORCID: https://orcid.org/0000-0003-1978-1559)
- Gabrielle Louise Langron Chau
Institutions
- The University of Sydney (AU)
- Westmead Hospital (AU)
- Westmead Institute (AU)
- Sydney Local Health District (AU)
- Westmead Institute for Medical Research (AU)
Publication Details
- Journal
- Medical Mycology
- Published
- 2025-08-18
- DOI
- https://doi.org/10.1093/mmy/myaf074
- Primary Topic
- Pharmaceutical industry and healthcare
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer
- Gilead Sciences